BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 8806714)

  • 1. Phosphorylation of calmodulin in the first calcium-binding pocket by myosin light chain kinase.
    Davis HW; Crimmins DL; Thoma RS; Garcia JG
    Arch Biochem Biophys; 1996 Aug; 332(1):101-9. PubMed ID: 8806714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutron-scattering studies reveal further details of the Ca2+/calmodulin-dependent activation mechanism of myosin light chain kinase.
    Krueger JK; Zhi G; Stull JT; Trewhella J
    Biochemistry; 1998 Oct; 37(40):13997-4004. PubMed ID: 9760234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of phosphorylated myosin light chain kinase on the ATP-dependent actin-myosin interaction.
    Samizo K; Okagaki T; Kohama K
    Biochem Biophys Res Commun; 1999 Jul; 261(1):95-9. PubMed ID: 10405329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of calmodulin-activated smooth-muscle myosin light-chain kinase by calmodulin-binding peptides and fluorescent (phosphodiesterase-activating) calmodulin derivatives.
    Török K; Cowley DJ; Brandmeier BD; Howell S; Aitken A; Trentham DR
    Biochemistry; 1998 Apr; 37(17):6188-98. PubMed ID: 9558358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The characterization of Ca(2+)-calmodulin independent phosphorylation of myosin light chains by a fragment from myosin light chain kinase.
    Yang JX; Wang XM; Tang ZY; Chen H; Xu H; Lin Y
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Sep; 35(9):793-800. PubMed ID: 12958650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the N-terminal region of the skeletal muscle myosin light chain kinase target sequence in its interaction with calmodulin.
    Findlay WA; Gradwell MJ; Bayley PM
    Protein Sci; 1995 Nov; 4(11):2375-82. PubMed ID: 8563635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of an epitope-tagged calmodulin useful for the analysis of calmodulin-binding proteins: addition of a hemagglutinin epitope does not affect calmodulin-dependent activation of smooth muscle myosin light chain kinase.
    Szymanska G; O'Connor MB; O'Connor CM
    Anal Biochem; 1997 Oct; 252(1):96-105. PubMed ID: 9324946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the high affinity and low sequence specificity of calmodulin binding to its targets.
    Afshar M; Caves LS; Guimard L; Hubbard RE; Calas B; Grassy G; Haiech J
    J Mol Biol; 1994 Dec; 244(5):554-71. PubMed ID: 7990140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical regulation of the nonmuscle myosin light chain kinase isoform in bovine endothelium.
    Verin AD; Gilbert-McClain LI; Patterson CE; Garcia JG
    Am J Respir Cell Mol Biol; 1998 Nov; 19(5):767-76. PubMed ID: 9806741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A subset of protein kinase C phosphorylation sites on the myosin II regulatory light chain inhibits phosphorylation by myosin light chain kinase.
    Turbedsky K; Pollard TD; Bresnick AR
    Biochemistry; 1997 Feb; 36(8):2063-7. PubMed ID: 9047304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation analysis of the non-muscle myosin light chain kinase (MLCK) deletion constructs on CV1 fibroblast contractile activity and proliferation.
    Wadgaonkar R; Nurmukhambetova S; Zaiman AL; Garcia JG
    J Cell Biochem; 2003 Feb; 88(3):623-34. PubMed ID: 12532337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Mg2+-binding sites and the role of Mg2+ on target recognition by calmodulin.
    Ohki S; Ikura M; Zhang M
    Biochemistry; 1997 Apr; 36(14):4309-16. PubMed ID: 9100027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium regulation of non-kinase and kinase activities of recombinant myosin light-chain kinase and its mutants.
    Xie C; Zhang Y; Wang HH; Matsumoto A; Nakamura A; Ishikawa R; Yoshiyama S; Hayakawa K; Kohama K; Gao Y
    IUBMB Life; 2009 Nov; 61(11):1092-8. PubMed ID: 19859981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of calmodulin alters its potency as an activator of target enzymes.
    Quadroni M; L'Hostis EL; Corti C; Myagkikh I; Durussel I; Cox J; James P; Carafoli E
    Biochemistry; 1998 May; 37(18):6523-32. PubMed ID: 9572870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two nonmuscle myosin II heavy chain isoforms expressed in rabbit brains: filament forming properties, the effects of phosphorylation by protein kinase C and casein kinase II, and location of the phosphorylation sites.
    Murakami N; Chauhan VP; Elzinga M
    Biochemistry; 1998 Feb; 37(7):1989-2003. PubMed ID: 9485326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretical model of the interactions between Ca2+, calmodulin and myosin light chain kinase.
    Fajmut A; Brumen M; Schuster S
    FEBS Lett; 2005 Aug; 579(20):4361-6. PubMed ID: 16051224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KT5926, a potent and selective inhibitor of myosin light chain kinase.
    Nakanishi S; Yamada K; Iwahashi K; Kuroda K; Kase H
    Mol Pharmacol; 1990 Apr; 37(4):482-8. PubMed ID: 2325635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-dependent and -independent interactions of the calmodulin-binding domain of cyclic nucleotide phosphodiesterase with calmodulin.
    Yuan T; Walsh MP; Sutherland C; Fabian H; Vogel HJ
    Biochemistry; 1999 Feb; 38(5):1446-55. PubMed ID: 9931009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calmodulin-myosin light chain kinase inhibition changes fibroblast-populated collagen lattice contraction, cell migration, focal adhesion formation, and wound contraction.
    Levinson H; Moyer KE; Saggers GC; Ehrlich HP
    Wound Repair Regen; 2004; 12(5):505-11. PubMed ID: 15453832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myosin light chain phosphorylation and growth cone motility.
    Schmidt JT; Morgan P; Dowell N; Leu B
    J Neurobiol; 2002 Sep; 52(3):175-88. PubMed ID: 12210102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.